MYC Rearranged Aggressive B‐Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)

Supplemental Digital Content is available in the text

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 3; no. 6; pp. e305 - n/a
Main Authors Tisi, Maria Chiara, Ferrero, Simone, Dogliotti, Irene, Tecchio, Cristina, Carli, Giuseppe, Novo, Mattia, Stefani, Piero Maria, Rattotti, Sara, Balzarotti, Monica, Marino, Dario, Pelosini, Matteo, Romano, Alessandra, Flenghi, Leonardo, Zilioli, Vittorio Ruggero, Calimeri, Teresa, Di Napoli, Arianna, Zanni, Manuela, Finolezzi, Erica, Mosna, Federico, Gini, Guido, Mansueto, Giovanna, Di Rocco, Alice, Tomei, Gabriella, Sgherza, Nicola, Olivieri, Jacopo, Nassi, Luca, Piazza, Francesco, Fama, Angelo, Greco, Antonio, Giannoccaro, Margherita, Mazzone, Anna Maria, Visco, Carlo, Loseto, Giacomo, Zaja, Francesco
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer Health 01.12.2019
Wiley
Subjects
Letter
Online AccessGet full text

Cover

Abstract Supplemental Digital Content is available in the text
AbstractList Supplemental Digital Content is available in the text
Author Ferrero, Simone
Zanni, Manuela
Nassi, Luca
Fama, Angelo
Calimeri, Teresa
Gini, Guido
Visco, Carlo
Di Rocco, Alice
Tecchio, Cristina
Zilioli, Vittorio Ruggero
Mazzone, Anna Maria
Pelosini, Matteo
Greco, Antonio
Tomei, Gabriella
Zaja, Francesco
Mansueto, Giovanna
Rattotti, Sara
Dogliotti, Irene
Mosna, Federico
Balzarotti, Monica
Di Napoli, Arianna
Olivieri, Jacopo
Giannoccaro, Margherita
Novo, Mattia
Loseto, Giacomo
Marino, Dario
Flenghi, Leonardo
Finolezzi, Erica
Carli, Giuseppe
Stefani, Piero Maria
Tisi, Maria Chiara
Romano, Alessandra
Sgherza, Nicola
Piazza, Francesco
AuthorAffiliation 32 Department of Medicine, Section Hematology, University of Verona, Italy
9 Medical Oncology 1, Veneto Institute of Oncology IOV IRCCS, Padova, Italy
18 Hematology and BMT Unit, Ospedale Centrale San Maurizio, ASDAA, Bolzano, Italy
30 Hematology, ASL Le/1 P.O. Vito Fazzi, Lecce, Italy
2 Institute of Hematology, Catholic University of the Sacred Heart, Rome, Italy
24 Hematology, Ospedale di Civitanova Marche, Civitanova Marche, Italy
17 Hematology, Transfusional Medicine and Biotechnologies, UOSD “Centro Diagnosi e Terapia dei Linfomi”, PO Santo Spirito, Pescara, Italy
11 Hematology, AOU Policlinico Vittorio Emanuele, Catania, Italy
20 Hematology and Stem Cell Transplantation Unit, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy
13 Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
23 Hematology, IRCCS Ospedale Casa Sollievo Sofferenza, S. G. Rotondo, Italy
19 Hematology Clinic, Department of Clinical and Molecular Sciences, Marche Po
AuthorAffiliation_xml – name: 14 Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy
– name: 30 Hematology, ASL Le/1 P.O. Vito Fazzi, Lecce, Italy
– name: 20 Hematology and Stem Cell Transplantation Unit, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy
– name: 31 Hematology, ASL Taranto, Taranto, Italy
– name: 28 Hematology, Azienda Unità Sanitaria Locale di Reggio Emilia – IRCCS, Reggio Emilia, Italy
– name: 17 Hematology, Transfusional Medicine and Biotechnologies, UOSD “Centro Diagnosi e Terapia dei Linfomi”, PO Santo Spirito, Pescara, Italy
– name: 21 Cellular Biotechnologies and Hematology, 'Sapienza University’, Rome, Italy
– name: 29 Hematology and BM transplant unit A.O.C. Panico Tricase (Le), Italy
– name: 5 Division of Hematology 2, AOU “Città della Salute e della Scienza di Torino”, Torino, Italy
– name: 23 Hematology, IRCCS Ospedale Casa Sollievo Sofferenza, S. G. Rotondo, Italy
– name: 8 Hematology Unit, Humanitas Clinical and Research Center – IRCCS - Rozzano/Milano, Italy
– name: 2 Institute of Hematology, Catholic University of the Sacred Heart, Rome, Italy
– name: 32 Department of Medicine, Section Hematology, University of Verona, Italy
– name: 7 Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
– name: 27 Hematology, University of Padova, Padova, Italy
– name: 24 Hematology, Ospedale di Civitanova Marche, Civitanova Marche, Italy
– name: 1 Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
– name: 15 Department of Clinical and Molecular Medicine, Roma Sapienza University, Sant’Andrea Hospital, Rome, Italy
– name: 16 Hematology, AO SS Antonio e Biagio, Alessandria, Italy
– name: 22 Hematology, Ospedale di Ivrea-ASL TO4, Ivrea, Italy
– name: 19 Hematology Clinic, Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy
– name: 25 Clinica Ematologica, Centro Trapianti e Terapie Cellulari “Carlo Melzi”, Azienda Sanitaria Universitaria Integrata di Udine, Italy
– name: 11 Hematology, AOU Policlinico Vittorio Emanuele, Catania, Italy
– name: 12 Hematology, O. Santa Maria della Misericordia, Perugia, Italy
– name: 6 HEMATOLOGY UNIT Department of Medicine, General Hospital TREVISO, Italy
– name: 18 Hematology and BMT Unit, Ospedale Centrale San Maurizio, ASDAA, Bolzano, Italy
– name: 9 Medical Oncology 1, Veneto Institute of Oncology IOV IRCCS, Padova, Italy
– name: 34 Hematology, Azienda Sanitaria Universitaria Integrata Trieste, Italy
– name: 13 Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
– name: 4 Medicine, Section of Hematology and Bone Marrow Transplant Unit, University of Verona, Verona, Italy
– name: 26 SCDU Ematologia, AOU Maggiore della Carità, Novara, Italy
– name: 33 Hematology and Cell Therapy Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy
– name: 3 Division of Hematology 1, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU “Città della Salute e della Scienza di Torino”, Torino, Italy
– name: 10 Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy
Author_xml – sequence: 1
  givenname: Maria Chiara
  surname: Tisi
  fullname: Tisi, Maria Chiara
  organization: Catholic University of the Sacred Heart
– sequence: 2
  givenname: Simone
  surname: Ferrero
  fullname: Ferrero, Simone
  email: simone.ferrero@unito.it
  organization: University of Torino/AOU “Città della Salute e della Scienza di Torino”
– sequence: 3
  givenname: Irene
  surname: Dogliotti
  fullname: Dogliotti, Irene
  organization: University of Torino/AOU “Città della Salute e della Scienza di Torino”
– sequence: 4
  givenname: Cristina
  surname: Tecchio
  fullname: Tecchio, Cristina
  organization: University of Verona
– sequence: 5
  givenname: Giuseppe
  surname: Carli
  fullname: Carli, Giuseppe
  organization: San Bortolo Hospital
– sequence: 6
  givenname: Mattia
  surname: Novo
  fullname: Novo, Mattia
  organization: AOU “Città della Salute e della Scienza di Torino”
– sequence: 7
  givenname: Piero Maria
  surname: Stefani
  fullname: Stefani, Piero Maria
  organization: General Hospital TREVISO
– sequence: 8
  givenname: Sara
  surname: Rattotti
  fullname: Rattotti, Sara
  organization: Fondazione IRCCS Policlinico San Matteo
– sequence: 9
  givenname: Monica
  surname: Balzarotti
  fullname: Balzarotti, Monica
  organization: Humanitas Clinical and Research Center – IRCCS
– sequence: 10
  givenname: Dario
  surname: Marino
  fullname: Marino, Dario
  organization: Veneto Institute of Oncology IOV IRCCS
– sequence: 11
  givenname: Matteo
  surname: Pelosini
  fullname: Pelosini, Matteo
  organization: University of Pisa
– sequence: 12
  givenname: Alessandra
  surname: Romano
  fullname: Romano, Alessandra
  organization: AOU Policlinico Vittorio Emanuele
– sequence: 13
  givenname: Leonardo
  surname: Flenghi
  fullname: Flenghi, Leonardo
  organization: O. Santa Maria della Misericordia
– sequence: 14
  givenname: Vittorio Ruggero
  surname: Zilioli
  fullname: Zilioli, Vittorio Ruggero
  organization: ASST Grande Ospedale Metropolitano Niguarda
– sequence: 15
  givenname: Teresa
  surname: Calimeri
  fullname: Calimeri, Teresa
  organization: IRCCS San Raffaele Scientific Institute
– sequence: 16
  givenname: Arianna
  surname: Di Napoli
  fullname: Di Napoli, Arianna
  organization: Sant'Andrea Hospital
– sequence: 17
  givenname: Manuela
  surname: Zanni
  fullname: Zanni, Manuela
  organization: AO SS Antonio e Biagio
– sequence: 18
  givenname: Erica
  surname: Finolezzi
  fullname: Finolezzi, Erica
  organization: PO Santo Spirito
– sequence: 19
  givenname: Federico
  surname: Mosna
  fullname: Mosna, Federico
  organization: ASDAA
– sequence: 20
  givenname: Guido
  surname: Gini
  fullname: Gini, Guido
  organization: Marche Polytechnic University
– sequence: 21
  givenname: Giovanna
  surname: Mansueto
  fullname: Mansueto, Giovanna
  organization: Referral Cancer Center of Basilicata
– sequence: 22
  givenname: Alice
  surname: Di Rocco
  fullname: Di Rocco, Alice
  organization: 'Sapienza University’
– sequence: 23
  givenname: Gabriella
  surname: Tomei
  fullname: Tomei, Gabriella
  organization: Ospedale di Ivrea‐ASL TO4
– sequence: 24
  givenname: Nicola
  surname: Sgherza
  fullname: Sgherza, Nicola
  organization: IRCCS Ospedale Casa Sollievo Sofferenza
– sequence: 25
  givenname: Jacopo
  surname: Olivieri
  fullname: Olivieri, Jacopo
  organization: Azienda Sanitaria Universitaria Integrata di Udine
– sequence: 26
  givenname: Luca
  surname: Nassi
  fullname: Nassi, Luca
  organization: AOU Maggiore della Carità
– sequence: 27
  givenname: Francesco
  surname: Piazza
  fullname: Piazza, Francesco
  organization: University of Padova
– sequence: 28
  givenname: Angelo
  surname: Fama
  fullname: Fama, Angelo
  organization: Azienda Unità Sanitaria Locale di Reggio Emilia – IRCCS
– sequence: 29
  givenname: Antonio
  surname: Greco
  fullname: Greco, Antonio
  organization: Hematology and BM transplant unit A.O.C. Panico Tricase (Le)
– sequence: 30
  givenname: Margherita
  surname: Giannoccaro
  fullname: Giannoccaro, Margherita
  organization: ASL Le/1 P.O. Vito Fazzi
– sequence: 31
  givenname: Anna Maria
  surname: Mazzone
  fullname: Mazzone, Anna Maria
  organization: ASL Taranto
– sequence: 32
  givenname: Carlo
  surname: Visco
  fullname: Visco, Carlo
  organization: University of Verona
– sequence: 33
  givenname: Giacomo
  surname: Loseto
  fullname: Loseto, Giacomo
  organization: IRCCS Istituto Tumori “Giovanni Paolo II”
– sequence: 34
  givenname: Francesco
  surname: Zaja
  fullname: Zaja, Francesco
  organization: Azienda Sanitaria Universitaria Integrata Trieste
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31976479$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1uEzEQx1eoiJbSN0DIx3JI8ed6FwmkNGpIpFQgPg6crFnvbOJqdx3sTVE48Qg8As_Co_AkGFKqlBO-jOX5z88z83-YHfS-xyx7zOgZo6V-NntXntH9I6i6lx1xpfmo5JId7N0Ps5MYr5KGlWWZc_0gOxSs1LnU5VG2vvw4IW8RQoB-iTUZL5cBY3TXSM5_fv02wbYli223XvkO4nMyTtq1DwPxPWGU_vj-BgaH_RCJb8iwQjL1fQ1fXOqWzAdoHfRAFq5vfOfI6XS-ePoou99AG_HkJh5nH6YX7yez0eL1q_lkvBhZxQs5QpBCN9hIXRe0AVsJZBQhF1KCBmYl5rVUtKoUE1ywQtQyr8qirlWdswYacZzNd9zaw5VZB9dB2BoPzvx58GFpIAzOtmisojpHS61SVqqqKjlqZFWVs7wAqWlivdyx1puqw9qmgQO0d6B3M71bmaW_Nnnav1IyAU5vAMF_2mAcTOeiTbuFHv0mGp7G4lqqgiep3Elt8DEGbG6_YdT89t4k782_3qeyJ_st3hb9dToJXuwEn12L2_-CmtnFpTifUl4wKX4Bsf-9gQ
CitedBy_id crossref_primary_10_3389_fonc_2023_1188478
crossref_primary_10_1002_ccr3_3817
crossref_primary_10_1182_bloodadvances_2023010704
crossref_primary_10_1002_hon_3130
Cites_doi 10.1038/s41591-018-0016-8
10.1182/blood-2009-03-212191
10.1111/bjh.13463
10.1016/S2352-3026(18)30177-7
10.1182/blood-2014-05-578963
10.3324/haematol.2018.190157
10.1056/NEJMoa1801445
10.1182/blood-2017-12-820605
10.1182/blood-2018-03-836361
10.1200/JCO.18.01583
10.1182/blood-2016-01-643569
10.3324/haematol.2012.066209
10.1093/annonc/mdy450
10.1111/bjh.12982
10.1038/modpathol.2013.214
ContentType Journal Article
Copyright Copyright © 2019 The Author(s).
Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.
Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. 2019
Copyright_xml – notice: Copyright © 2019 The Author(s).
– notice: Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.
– notice: Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. 2019
DBID 24P
WIN
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1097/HS9.0000000000000305
DatabaseName Wiley_OA刊
Wiley-Blackwell Backfiles (Open access)
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley-Blackwell Titles (Open access)
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2572-9241
EndPage n/a
ExternalDocumentID oai_doaj_org_article_c5076ec0c55c45bb92e7e1bb6168a470
10_1097_HS9_0000000000000305
31976479
HEM3BF02814
Genre letter
Journal Article
GrantInformation_xml – fundername: Fondazione Neoplasie Del Sangue (Fo.Ne.Sa), Torino, Italy
– fundername: Fondazione CRT
  funderid: 2016.0677; 2018.1284
– fundername: Associazione DaRosa, Torino, Italy
– fundername: Fondi di Ricerca Locale
– fundername: Università degli Studi di Torino, Italy
GroupedDBID 0R~
24P
53G
AAAAV
AAHPQ
AASCR
ABASU
ABDIG
ABVCZ
ACGFS
ACILI
ACXJB
ADBBV
ADGGA
ADHPY
ADPDF
AFDTB
AFKRA
AHQNM
AHVBC
AINUH
AJIOK
AJNWD
AJZMW
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
BCNDV
BENPR
CCPQU
DIWNM
EBS
EEVPB
FCALG
GNXGY
GQDEL
GROUPED_DOAJ
HLJTE
HYE
IKREB
M~E
OK1
OPUJH
OVD
OVDNE
OVEED
OXXIT
PIMPY
RLZ
RPM
TEORI
TSPGW
WIN
BQLVK
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c5284-ea437fef47d80facb3e10ea6344a7a1c4e6d450bb51323183d46b98dd5d61faf3
IEDL.DBID RPM
ISSN 2572-9241
IngestDate Tue Oct 22 15:14:30 EDT 2024
Tue Sep 17 21:21:49 EDT 2024
Sat Aug 17 03:14:56 EDT 2024
Fri Aug 23 02:20:49 EDT 2024
Wed Oct 16 00:44:24 EDT 2024
Sat Aug 24 00:56:41 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License Attribution
Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.
This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5284-ea437fef47d80facb3e10ea6344a7a1c4e6d450bb51323183d46b98dd5d61faf3
Notes This work was supported by: Fondi di Ricerca Locale, Università degli Studi di Torino, Italy; Fondazione Neoplasie Del Sangue (Fo.Ne.Sa), Torino, Italy; Fondazione CRT (projects code: 2016.0677, 2018.1284), Torino, Italy; Associazione DaRosa, Torino, Italy.
www.hemaspherejournal.com
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website
The authors declare no conflicts of interest.
Maria Chiara Tisi and Simone Ferrero are the co‐authors and equally contributed to the work.
.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924554/
PMID 31976479
PQID 2344274582
PQPubID 23479
PageCount 4
ParticipantIDs doaj_primary_oai_doaj_org_article_c5076ec0c55c45bb92e7e1bb6168a470
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6924554
proquest_miscellaneous_2344274582
crossref_primary_10_1097_HS9_0000000000000305
pubmed_primary_31976479
wiley_primary_10_1097_HS9_0000000000000305_HEM3BF02814
PublicationCentury 2000
PublicationDate December 2019
PublicationDateYYYYMMDD 2019-12-01
PublicationDate_xml – month: 12
  year: 2019
  text: December 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle HemaSphere
PublicationTitleAlternate Hemasphere
PublicationYear 2019
Publisher Wolters Kluwer Health
Wiley
Publisher_xml – name: Wolters Kluwer Health
– name: Wiley
References 2018; 131
2018; 29
2015; 170
2018; 5
2013; 98
2019; 37
2018; 103
2018; 378
2014; 27
2016; 127
2014; 166
2009; 114
2014; 124
2018; 24
Oki (R8-20231021) 2014; 166
Dunleavy (R4-20231021) 2018; 5
Tzankov (R7-20231021) 2014; 27
Ennishi (R12-20231021) 2019; 37
Visco (R6-20231021) 2013; 98
Howlett (R5-20231021) 2015; 170
McPhail (R3-20231021) 2018; 103
Scott (R10-20231021) 2018; 131
Ciavarella (R15-20231021) 2018; 29
Johnson (R9-20231021) 2009; 114
Copie-Bergman (R11-20231021) 2018; 131
Schmitz (R13-20231021) 2018; 378
Swerdlow (R1-20231021) 2016; 127
Petrich (R2-20231021) 2014; 124
Chapuy (R14-20231021) 2018; 24
References_xml – volume: 127
  start-page: 2375
  year: 2016
  end-page: 2390
  article-title: The 2016 revision of the World Health Organization classification of lymphoid neoplasms
  publication-title: Blood
– volume: 131
  start-page: 2060
  year: 2018
  end-page: 2064
  article-title: High‐grade B‐cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B‐cell lymphoma morphology
  publication-title: Blood
– volume: 27
  start-page: 958
  year: 2014
  end-page: 971
  article-title: Rearrangements of MYC gene facilitate risk stratification in diffuse large B‐cell lymphoma patients treated with rituximab‐CHOP
  publication-title: Mod Pathol
– volume: 24
  start-page: 679
  year: 2018
  end-page: 690
  article-title: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
  publication-title: Nat Med
– volume: 37
  start-page: 190
  year: 2019
  end-page: 201
  article-title: Double‐hit gene expression signature defines a distinct subgroup of germinal center B‐Cell‐like diffuse large B‐Cell lymphoma
  publication-title: J Clin Oncol
– volume: 5
  start-page: e609
  year: 2018
  end-page: e617
  article-title: Dose‐adjusted EPOCH‐R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B‐cell lymphoma with MYC rearrangement: a prospective, multicentre, single‐arm phase 2 study
  publication-title: Lancet Haematol
– volume: 29
  start-page: 2363
  year: 2018
  end-page: 2370
  article-title: Dissection of DLBCL microenvironment provides a gene expression‐based predictor of survival applicable to formalin‐fixed paraffin‐embedded tissue
  publication-title: Ann Oncol
– volume: 170
  start-page: 504
  year: 2015
  end-page: 514
  article-title: Front‐line, dose‐escalated immunochemotherapy is associated with a significant progression‐free survival advantage in patients with double‐hit lymphomas: a systematic review and meta‐analysis
  publication-title: Br J Haematol
– volume: 98
  start-page: 255
  year: 2013
  end-page: 263
  article-title: Patients with diffuse large B‐cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab‐CHOP Consortium Program Study
  publication-title: Haematologica
– volume: 131
  start-page: 1997
  year: 2018
  end-page: 1998
  article-title: Double‐hit DLBCL: should we limit FISH testing?
  publication-title: Blood
– volume: 166
  start-page: 891
  year: 2014
  end-page: 901
  article-title: Double hit lymphoma: the MD Anderson Cancer Center clinical experience
  publication-title: Br J Haematol
– volume: 124
  start-page: 2354
  year: 2014
  end-page: 2361
  article-title: Impact of induction regimen and stem cell transplantation on outcomes in double‐hit lymphoma: a multicenter retrospective analysis
  publication-title: Blood
– volume: 103
  start-page: 1899
  year: 2018
  end-page: 1907
  article-title: Inferior survival in high‐grade B‐cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements
  publication-title: Haematologica
– volume: 378
  start-page: 1396
  year: 2018
  end-page: 1407
  article-title: Genetics and pathogenesis of diffuse large B‐Cell lymphoma
  publication-title: N Engl J Med
– volume: 114
  start-page: 2273
  year: 2009
  end-page: 2279
  article-title: Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
  publication-title: Blood
– volume: 24
  start-page: 679
  year: 2018
  ident: R14-20231021
  article-title: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
  publication-title: Nat Med.
  doi: 10.1038/s41591-018-0016-8
  contributor:
    fullname: Chapuy
– volume: 114
  start-page: 2273
  year: 2009
  ident: R9-20231021
  article-title: Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
  publication-title: Blood.
  doi: 10.1182/blood-2009-03-212191
  contributor:
    fullname: Johnson
– volume: 170
  start-page: 504
  year: 2015
  ident: R5-20231021
  article-title: Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis
  publication-title: Br J Haematol.
  doi: 10.1111/bjh.13463
  contributor:
    fullname: Howlett
– volume: 5
  start-page: e609
  year: 2018
  ident: R4-20231021
  article-title: Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study
  publication-title: Lancet Haematol.
  doi: 10.1016/S2352-3026(18)30177-7
  contributor:
    fullname: Dunleavy
– volume: 124
  start-page: 2354
  year: 2014
  ident: R2-20231021
  article-title: Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
  publication-title: Blood.
  doi: 10.1182/blood-2014-05-578963
  contributor:
    fullname: Petrich
– volume: 103
  start-page: 1899
  year: 2018
  ident: R3-20231021
  article-title: Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements
  publication-title: Haematologica.
  doi: 10.3324/haematol.2018.190157
  contributor:
    fullname: McPhail
– volume: 378
  start-page: 1396
  year: 2018
  ident: R13-20231021
  article-title: Genetics and pathogenesis of diffuse large B-Cell lymphoma
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMoa1801445
  contributor:
    fullname: Schmitz
– volume: 131
  start-page: 2060
  year: 2018
  ident: R10-20231021
  article-title: High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology
  publication-title: Blood.
  doi: 10.1182/blood-2017-12-820605
  contributor:
    fullname: Scott
– volume: 131
  start-page: 1997
  year: 2018
  ident: R11-20231021
  article-title: Double-hit DLBCL: should we limit FISH testing?
  publication-title: Blood.
  doi: 10.1182/blood-2018-03-836361
  contributor:
    fullname: Copie-Bergman
– volume: 37
  start-page: 190
  year: 2019
  ident: R12-20231021
  article-title: Double-hit gene expression signature defines a distinct subgroup of germinal center B-Cell-like diffuse large B-Cell lymphoma
  publication-title: J Clin Oncol.
  doi: 10.1200/JCO.18.01583
  contributor:
    fullname: Ennishi
– volume: 127
  start-page: 2375
  year: 2016
  ident: R1-20231021
  article-title: The 2016 revision of the World Health Organization classification of lymphoid neoplasms
  publication-title: Blood.
  doi: 10.1182/blood-2016-01-643569
  contributor:
    fullname: Swerdlow
– volume: 98
  start-page: 255
  year: 2013
  ident: R6-20231021
  article-title: Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
  publication-title: Haematologica.
  doi: 10.3324/haematol.2012.066209
  contributor:
    fullname: Visco
– volume: 29
  start-page: 2363
  year: 2018
  ident: R15-20231021
  article-title: Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue
  publication-title: Ann Oncol.
  doi: 10.1093/annonc/mdy450
  contributor:
    fullname: Ciavarella
– volume: 166
  start-page: 891
  year: 2014
  ident: R8-20231021
  article-title: Double hit lymphoma: the MD Anderson Cancer Center clinical experience
  publication-title: Br J Haematol.
  doi: 10.1111/bjh.12982
  contributor:
    fullname: Oki
– volume: 27
  start-page: 958
  year: 2014
  ident: R7-20231021
  article-title: Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
  publication-title: Mod Pathol.
  doi: 10.1038/modpathol.2013.214
  contributor:
    fullname: Tzankov
SSID ssj0001999627
Score 2.1734376
Snippet Supplemental Digital Content is available in the text
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e305
SubjectTerms Letter
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQiFeAVoPEAQ5W48SPhNvuqtEW7SIEVCqnyI4nUKnNonZ7gF_fsb2pdgEJDuQUJVH8mLHnm_H4M2OvDKKTqnbcoLNcksXkjhSDo8-drmy4D_GO5Xs9P5HvTtXp1lFfIScs0QOnjjvsCLBo7PJOqU4q5-oCDQrntKBfSZO8daG2nKkYXQk4vjDjXrnaHM4_1YmrcLzKcGLdli2KlP1_wpm_p0tuw9hoh5r77N4GQMIkVfwBu4PDQ3ax_DKDjyHtNuwV8DD5Gt1omslgymd4fg6LHyS2kAv0FiaQUDesBhB5Dh8SteoVrHogOAjNitz0n4HBCI7XMQxiYREU8eIMXjfHizeP2Elz9Hk255uDFHinyPxwtLI0PfbS-CrvbedKFDlaXUppjRWdRO2lyp1T5JuGQe6ldnXlvfJa9LYvH7O9gUp9yqDILXpLsK7sS1mp2gpHUhba9lgZNC5jfOzS9nviy2jHdW4SQfurCDI2Df1--21gu44PSAfajQ60f9OBjL0cpdbS6AhLHnbA1fVVW1ATye9WVZGxJ0mKt0XR5GO0NHXGzI58d-qy-2Y4-xYZuDV5rYTDMqajJvxTS9v50bKcNoTnhHz2P1r9nN0l9Fan3JoXbG99eY37hJDW7iAOhhsK_ggl
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Wiley_OA刊
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWqsmGDQLzCS0ZiAQurduJH0t3MqNEUzaAKqFRWkR3ftJVKUnWmi7LiE_gEvoVP4Uu4diZTBrpAZBXl5dj3XPtcP44JeWUAnFSFYwacZRJbTOYQGAw8dzq34Tz0d8zf6emhfHukjrZIOayF6fUh1h1uwTNifR0c3LrFzrV47PRD0YsPDkcWpExvIcPJA7pTeXDd1xJYfdy9FQGaMgw5xLCKrjA7N31oo5WKYv43MdC_J1L-TnBjC1XeJXdW1JKOeizcI1vQ3ifn808T-j5MyA2rCDwdHccAG-s4Ov759dsEzs7o7ApNGuYJ7dIR7Rk57VoqOP_x_aDXXV3QrqHIFWnZYQz_Jcgb0f1l7COxdBZQ-vmUvi73Z28ekMNy7-Nkyla7LLBaYdvEwMrMNNBI43Pe2NplIDhYnUlpjRW1BO2l4s4pDFxDDeCldkXuvfJaNLbJHpLtFlN9TGjKLXiLnC9rMpmrwgqHEBDaNpAbMC4hbCjV6rwX06iGQXC0QvWnFRIyDkW_fjZIYccL3cVxtfKsqkZGq6HmtVK1VM4VKRgQzmmBWJOGJ-TlYLgKXSeMh9gWustFlWIWMShXeZqQR70h10lhzWS0NEVCzIaJN_5l8057ehLluTXiC0laQnQEwz_ltJruzbNxiWRPyCf_--JTchvpXNFPtnlGtpcXl_AcKdPSvYj-8AtA7wiy
  priority: 102
  providerName: Wiley-Blackwell
Title MYC Rearranged Aggressive B‐Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)
URI https://onlinelibrary.wiley.com/doi/abs/10.1097%2FHS9.0000000000000305
https://www.ncbi.nlm.nih.gov/pubmed/31976479
https://search.proquest.com/docview/2344274582
https://pubmed.ncbi.nlm.nih.gov/PMC6924554
https://doaj.org/article/c5076ec0c55c45bb92e7e1bb6168a470
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB41RUK9IBAv84gWiQMc3PixD5tbEmKlKIEIKCona9cet5ESu2rTA_x6ZtdxlQAHhE-WbWm9-33r-WZ2dgzwWiEaLlLjKzTa52QxfUPE8LEMjEy0PbfxjvlHOT3lH87E2QGIbi-MS9ovzPK4Xq2P6-WFy628XBeDLk9ssJiPJTkNZAYHPeipON5x0V1gxUr4SHXb5FI1mH5J2zKF3UEcP4K7RD4luc3h2rFIrnD_39Tmn0mTu2LWWaPsPtzbykg2bF_3ARxg_RDW8-9j9tkm39odAyUbnjtnmr5nbOSPcbVisx8Ens0IeseGrNXerKlZGARs0RZYvWZNxUgUsqwhZ_2nrWPETjYuGKLZzNJxvWRvspPZ20dwmk2-jqf-9ncKfiHICPmoeawqrLgqk6DShYkxDFDLmHOtdFhwlCUXgTGCPFQ71UsuTZqUpShlWOkqfgyHNbX6FFgUaCw1ibu4inkiUh0awjqUusJEoTIe-N2Q5pdt1Yy8W-0mNPLf0fBgZMf99llb89pdaK7O8y3yeUHSVWIRFEIUXBiTRqgwNEaGRCquAg9edajlNEfswoeusbm5ziPqInnfIok8eNKieNtUxwIP1B6-e--yf4do6epwb2nogXRM-Kee5tPJPB5lpOpC_uy_m3wORyTc0jat5gUcbq5u8CWJo43pQy_ii74LLfThzqdvk8n7vpsgvwAi3AwG
link.rule.ids 230,315,733,786,790,870,891,2115,11589,27955,27956,46085,46509,53825,53827
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VIkEvPAQU81wkDnBw4sc-bG5JVMsBu6qgReVk7drrEpHYVZsc6K9ndh1XSeEA-GR5La3H863nm91vxwBvhdaKsli5QivpUoyYrkJguLryFI-kOTfzHfkhT0_ox1N2ugOs3wtjRfulmg2a-WLQzL5bbeX5ohz2OrHhUT7hmDRgGBzegts4XgO2kaTbqRVD4gPRb5SLxTD9EneFCvsDUb4HdxB-glOj4tqISbZ0_5_45u-yyU06a-NRch--9pZ0MpQfg9VSDcqrG0Ue_9nUB3BvzVDJqGt-CDu6eQSL_NuEfDa6XrMZoSKjM5un46eSjN2Jns9J9hNxYcRGH8iIdLSetA3xPY8cdbVbL0lbE-SbJGmbSl6ZEklkurTzLJJkBumLGXmXTLP3j-EkOTiepO76Tw1uyTC-uVrSUNS6pqKKvFqWKtS-pyUPKZVC-iXVvKLMU4ph8mu-IhXlKo6qilXcr2UdPoHdBnt9CiTwpK4k8sawDmnEYukrhJHPZa0joYVywO19VZx3BTmKfiEd3VzcdLMDY-PQ63tNOW17ob04K9ZvuiiRFXNdeiVjJWVKxYEW2leK-4hXKjwH3vRwKHD4mTUV2eh2dVkEaCIm9iwKHNjv4HHdVQ8vB8QWcLaeZbsFYWBLfK_d7gC3EPsrS4v0IA_HCRJGnz777y5fw930OM-KbHr46TnsIT-MO_XOC9hdXqz0S-RgS_XKjrhfO9MqnQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD6CIU174SJu2bgYiQd4SHPzJeGtLYtaaKcKmDR4iezYGRVtWm3tA_v1HDvN1A4e0PIUJZYc53z2-Y79-RjgrTBGUZYpXxglfYoe01cIDN_oUPFU2ns73zE-4YNT-umMnW0d9eVE-6WadurZvFNPfzpt5XJeBq1OLJiM-xyDBnSDwVJXwV24h302FluBuptesUQ-Fu1muUwEg69Zk6ywvRDpB7CPEBScWiXXll9y6fv_xTn_lk5uU1rnk_IH8KNtTSNF-dVZr1SnvLqR6PFWzX0I9zdMlXSbIo_gjqkfw3z8vU--WH2v3ZSgSffcxes4ZJKe3zezGRn9RnxY0dEH0iUNvSeLmkRhSCZNDtdLsqgI8k6SL2otr2yqJDJcufkWSUYW8fMpeZcPR--fwGl-_K0_8DcnNvglQz_nG0kTUZmKCp2GlSxVYqLQSJ5QKoWMSmq4pixUimEQbEcTTbnKUq2Z5lElq-Qp7NVY63MgcSiNlsgfkyqhKctkpBBOEZeVSYURygO_tVexbBJzFO2COpq6uGlqD3rWqNdlbVpt92BxcV5s_nZRIjvmpgxLxkrKlMpiI0ykFI8Qt1SEHrxpIVFgN7RrK7I2i_VlEWMTMcBnaezBswYi11W1EPNA7IBn51t23yAUXKrvjek94A5m_9XSYnA8Tno5EseIHt66ytewP_mYF6PhyecjOECamDUinhewt7pYm5dIxVbqlet0fwDBOS0d
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MYC+Rearranged+Aggressive+B-Cell+Lymphomas%3A+A+Report+on+100+Patients+of+the+Fondazione+Italiana+Linfomi+%28FIL%29&rft.jtitle=HemaSphere&rft.au=Maria+Chiara+Tisi&rft.au=Simone+Ferrero&rft.au=Irene+Dogliotti&rft.au=Cristina+Tecchio&rft.date=2019-12-01&rft.pub=Wiley&rft.eissn=2572-9241&rft.volume=3&rft.issue=6&rft.spage=e305&rft_id=info:doi/10.1097%2FHS9.0000000000000305&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_c5076ec0c55c45bb92e7e1bb6168a470
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2572-9241&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2572-9241&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2572-9241&client=summon